Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies

por Boettcher, Michael, Gerisch, Michael, Lobmeyer, Maximilian, Besche, Nina, Thomas, Dirk, Gerrits, Mireille, Lemmen, Julia, Mueck, Wolfgang, Radtke, Martin, Becker, Corina
Publicado 2020

Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals

por Le, MyPhuong T., Lobmeyer, Maximilian T., Campbell, Marcus, Cheng, Jing, Wang, Zhiying, Turner, Stephen T., Chapman, Arlene B., Boerwinkle, Eric, Gums, John G., Gong, Yan, Johnson, Richard J., Johnson, Julie A.
Publicado 2013

Genome‐Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β‐Blockers

por Shahin, Mohamed H., Conrado, Daniela J., Gonzalez, Daniel, Gong, Yan, Lobmeyer, Maximilian T., Beitelshees, Amber L., Boerwinkle, Eric, Gums, John G., Chapman, Arlene, Turner, Stephen T., Cooper‐DeHoff, Rhonda M., Johnson, Julie A.
Publicado 2018

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients

por Willmann, Stefan, Marostica, Eleonora, Snelder, Nelleke, Solms, Alexander, Jensen, Markus, Lobmeyer, Maximilian, Lensing, Anthonie W. A., Bethune, Claudette, Morgan, Erin, Yu, Rosie Z., Wang, Yanfeng, Jung, Shiangtung W., Geary, Richard, Bhanot, Sanjay
Publicado 2021